Loránd Kis

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: APMIS. 2019;127(8):554-560
PD-L1 expression and deficient mismatch repair in ductal adenocarcinoma of the prostate
Lindh C; Kis L; Delahunt B; Samaratunga H; Yaxley J; Wiklund NP; Clements M; Egevad L
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2019;511(2):260-265
miR-100-5p confers resistance to ALK tyrosine kinase inhibitors Crizotinib and Lorlatinib in EML4-ALK positive NSCLC
Lai Y; Kacal M; Kanony M; Stukan I; Jatta K; Kis L; Norberg E; Vakifahmetoglu-Norberg H; Lewensohn R; Hydbring P; Ekman S
Article: IMMUNOLOGY. 2017;152(4):562-573
Epstein-Barr virus (EBV) provides survival factors to EBV⁺ diffuse large B-cell lymphoma (DLBCL) lines and modulates cytokine induced specific chemotaxis in EBV⁺DLBCL
Wu L; Ehlin-Henriksson B; Zhou X; Zhu H; Ernberg I; Kis LL; Klein G
Article: NATURE BIOMEDICAL ENGINEERING. 2017;1(10):796-806
Whole-tissue biopsy phenotyping of three-dimensional tumours reveals patterns of cancer heterogeneity
Tanaka N; Kanatani S; Tomer R; Sahlgren C; Kronqvist P; Kaczynska D; Louhivuori L; Kis L; Lindh C; Mitura P; Stepulak A; Corvigno S; Hartman J; Micke P; Mezheyeuski A; Strell C; Carlson JW; Moro CF; Dahlstrand H; Ostman A; Matsumoto K; Wiklund P; Oya M; Miyakawa A; Deisseroth K; Uhlen P
Article: SCIENTIFIC REPORTS. 2016;6:38037
Sequencing-based breast cancer diagnostics as an alternative to routine biomarkers.
Rantalainen M; Klevebring D; Lindberg J; Ivansson E; Rosin G; Kis L; Celebioglu F; Fredriksson I; Czene K; Frisell J; Hartman J; Bergh J; Grönberg H
Article: MODERN PATHOLOGY. 2016;29(4):318-329
Digital image analysis outperforms manual biomarker assessment in breast cancer
Stalhammar G; Martinez NF; Lippert M; Tobin NP; Molholm I; Kis L; Rosin G; Rantalainen M; Pedersen L; Bergh J; Grunkin M; Hartman J
Article: CANCER LETTERS. 2015;367(1):76-87
mTOR inhibitors counteract tamoxifen-induced activation of breast cancer stem cells
Karthik G-M; Ma R; Lovrot J; Kis LL; Lindh C; Blomquist L; Fredriksson I; Bergh J; Hartman J
Article: ANTICANCER RESEARCH. 2015;35(2):929-934
β-Catenin Helices in the Cytoplasm of Sessile Serrated Adenoma/Polyps and Conventional Colorectal Adenomas
Rubio CA; Kaufeldt A; Koha R; Ushoida M; Lindahl J; Kis LL
Article: CELL DEATH AND DISEASE. 2014;5(10):e1483
SIRT1 and SIRT2 inhibition impairs pediatric soft tissue sarcoma growth
Ma L; Maruwge W; Strambi A; D'Arcy P; Pellegrini P; Kis L; de Milito A; Lain S; Brodin B
Article: VIRCHOWS ARCHIV. 2013;463(5):637-642
Lymphoid aggregates in Crohn's colitis and mucosal immunity
Rubio CA; Asmundsson J; Silva P; Illies C; Hartman J; Kis L
Article: JOURNAL OF VIROLOGY. 2012;86(8):4701-4707
Latency Type-Dependent Modulation of Epstein-Barr Virus-Encoded Latent Membrane Protein 1 Expression by Type I Interferons in B Cells
Salamon D; Adori M; Ujvari D; Wu L; Kis LL; Madapura HS; Nagy N; Klein G; Klein E
Article: CYTOKINE. 2012;57(3):360-371
Type I interferons directly down-regulate BCL-6 in primary and transformed germinal center B cells: Differential regulation in B cell lines derived from endemic or sporadic Burkitt's lymphoma
Salmon D; Adori M; He M; Bonelt P; Severinson E; Kis LL; Wu L; Ujvari D; Leveau B; Nagy N; Klein G; Klein E
Article: INTERNATIONAL JOURNAL OF CANCER. 2012;130(1):48-58
Monocytes enhance cell proliferation and LMP1 expression of nasal natural killer/T-cell lymphoma cells by cell contact-dependent interaction through membrane-bound IL-15
Ishii H; Takahara M; Nagato T; Kis LL; Nagy N; Kishibe K; Harabuchi Y; Klein E
Article: BMC CANCER. 2011;11:441
Drug sensitivity patterns of HHV8 carrying body cavity lymphoma cell lines
Otvos R; Skribek H; Kis LL; Gloghini A; Markasz L; Flaberg E; Eksborg S; Konya J; Gergely L; Carbone A; Szekely L
Article: BLOOD. 2011;117(1):165-174
STAT6 signaling pathway activated by the cytokines IL-4 and IL-13 induces expression of the Epstein-Barr virus-encoded protein LMP-1 in absence of EBNA-2: implications for the type II EBV latent gene expression in Hodgkin lymphoma
Kis LL; Gerasimcik N; Salamon D; Persson EK; Nagy N; Klein G; Severinson E; Klein E
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2010;107(2):872-877
IL-21 imposes a type II EBV gene expression on type III and type I B cells by the repression of C- and activation of LMP-1-promoter
Kis LL; Salamon D; Persson EK; Nagy N; Scheeren FA; Spits H; Klein G; Klein E
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2009;106(29):11966-11971
The proapoptotic function of SAP provides a clue to the clinical picture of X-linked lymphoproliferative disease
Nagy N; Matskova L; Kis LL; Hellman U; Klein G; Klein E
Article: LEUKEMIA AND LYMPHOMA. 2007;48(9):1835-1845
Hodgkin-lymphoma-derived cells show high sensitivity to dactinomycin and paclitaxel
Markasz L; Kis LL; Stuber G; Flaberg E; Otvos R; Eksborg S; Skribek H; Olah E; Szekely L
Article: INTERNATIONAL JOURNAL OF CANCER. 2006;119(12):2775-2783
Concomitant increase of LMP1 and CD25 (IL-2-receptor α) expression induced by IL-10 in the EBV-positive NK lines SNK6 and KAI3
Takahara M; Kis LL; Nagy N; Liu A; Harabuchi Y; Klein G; Klein E
Article: BLOOD. 2006;107(7):2928-2935
IL-10 can induce the expression of EBV-encoded latent membrane protein-1 (LMP-1) in the absence of EBNA-2 in B lymphocytes and in Burkitt lymphoma-and NK lymphoma-derived cell lines
Kis LL; Takahara M; Nagy N; Klein G; Klein E
Article: JOURNAL OF PATHOLOGY. 2006;208(3):408-414
Differential expression of oestrogen receptors in human secondary lymphoid tissues
Shim GJ; Gherman D; Kim HJ; Omoto Y; Iwase H; Bouton D; Kis LL; Andersson CT; Warner M; Gustafsson J
Article: VIRUS GENES. 2005;30(3):323-330
EBV infection induces expression of the transcription factors ATF-2/c-Jun in B lymphocytes but not in B-CLL cells
Bandobashi K; Liu AQ; Nagy N; Kis LL; Nishikawa J; Björkholm M; Klein G; Klein E
Article: INTERNATIONAL JOURNAL OF CANCER. 2005;113(6):937-945
In vitro EBV-infected subline of KMH2, derived from Hodgkin lymphoma, expresses only EBNA-1, while CD40 ligand and IL-4 induce LMP-1 but not EBNA-2
Kis LL; Nishikawa J; Takahara M; Nagy N; Matskova L; Takada K; Elmberger PG; Ohlsson A; Klein G; Klein E
Article: ONCOGENE. 2004;23(53):8563-8570
Wild-type p53 activates SAP expression in lymphoid cells
Nagy N; Takahara M; Nishikawa J; Bourdon JC; Kis LL; Klein G; Klein E
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2004;101(6):1720-1724
Autoimmune glomerulonephritis with spontaneous formation of splenic germinal centers in mice lacking the estrogen receptor alpha gene.
Shim G-J; Kis LL; Warner M; Gustafsson J-A
Article: VIRUS GENES. 2004;28(1):121-128
Upregulation of LMP1 expression by histone deacetylase inhibitors in an EBV carrying NPC cell line
Nishikawa J; Kis LL; Liu AQ; Zhang XN; Takahara M; Bandobashi K; Kiss C; Nagy N; Okita K; Klein G; Klein E
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2003;100(11):6694-6699
Disruption of the estrogen receptor β gene in mice causes myeloproliferative disease resembling chronic myeloid leukemia with lymphoid blast crisis
Shim GJ; Wang L; Andersson S; Nagy N; Kis LL; Zhang QH; Mäkelä S; Warner M; Gustafsson J
Article: INTERNATIONAL JOURNAL OF CANCER. 2003;104(5):658-661
Expression of SH2D1A in five classical Hodgkin's disease-derived cell lines
Kis LL; Nagy N; Klein G; Klein E
Article: INTERNATIONAL JOURNAL OF CANCER. 2002;100(4):433-440
SH2D1A expression in Burkitt lymphoma cells is restricted to EBV positive group I lines and is downregulated in parallel with immunoblastic transformation
Nagy N; Maeda A; Bandobashi K; Kis LL; Nishikawa J; Trivedi P; Faggioni A; Klein G; Klein E
Visa fler

Alla övriga publikationer

Letter: BRITISH JOURNAL OF HAEMATOLOGY. 2018;180(5):744-748
CD274 (PD-L1)/PDCD1 (PD-1) expression in de novo and transformed diffuse large B-cell lymphoma
Kwiecinska A; Tsesmetzis N; Ghaderi M; Kis L; Saft L; Rassidakis GZ
Review: JOURNAL OF CLINICAL PATHOLOGY. 2018;71(1):7-11
The third pathway of colorectal carcinogenesis
Rubio CA; Puppa G; de Petris G; Kis L; Schmidt PT
Corrigendum: NATURE BIOMEDICAL ENGINEERING. 2018;2(1):48
Whole-tissue biopsy phenotyping of three-dimensional tumours reveals patterns of cancer heterogeneity (vol 1, pg 796, 2017)
Tanaka N; Kanatani S; Tomer R; Sahlgren C; Kronqvist P; Kaczynska D; Louhivuori L; Kis L; Lindh C; Mitura P; Stepulak A; Corvigno S; Hartman J; Micke P; Mezheyeuski A; Strell C; Carlson JW; Moro CF; Dahlstrand H; Ostman A; Matsumoto K; Wiklund P; Oya M; Miyakawa A; Deisseroth K; Uhlen P
Letter: ANNALS OF ONCOLOGY. 2017;28(7):1672-1673
Lethal aplastic anemia caused by dual immune checkpoint blockade in metastatic melanoma
Helgadottir H; Kis L; Ljungman P; Larkin J; Kefford R; Ascierto PA; Hansson J; Masucci G
Letter: LEUKEMIA. 2017;31(7):1633-1637
PD-L1 is commonly expressed and transcriptionally regulated by STAT3 and MYC in ALK-negative anaplastic large-cell lymphoma
Atsaves V; Tsesmetzis N; Chioureas D; Kis L; Leventaki V; Drakos E; Panaretakis T; Grander D; Medeiros LJ; Young KH; Rassidakis GZ
Thesis / dissertation: 2009
The role of the microenvironment on the regulation of Epstein-Barr virus latent gene expression
Kis, Loránd Levente
Review: ONCOGENE. 2007;26(9):1297-1305
Epstein-Barr virus infection in humans: from harmless to life endangering virus-lymphocyte interactions
Klein E; Kis LL; Klein G
Review: ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA. 2006;53(4):441-457
Pathogenesis of Epstein-Barr virus (EBV)-carrying lymphomas.
Klein E; Kis LL; Takahara M
Published conference paper: IMMUNOLOGY LETTERS. 2006;104(1-2):83-88
Cytokine mediated induction of the major Epstein-Barr virus (EBV)-encoded transforming protein, LMP-1
Kis LL; Takahara M; Nagy N; Klein G; Klein E
Letter: LEUKEMIA. 2005;19(10):1854-1856
Epigenetic mechanisms do not control viral latency III in primary effusion lymphoma cells infected with a recombinant Epstein-Barr virus
Anastasiadou E; Boccellato F; Cirone M; Kis LL; Klein E; Frati L; Faggioni A; Trivedi P

Anställningar

Anknuten till Forskning, Onkologi-Patologi, Karolinska Institutet, 2023-2026

Examina och utbildning

Medicine Doktorsexamen, Institutionen för mikrobiologi, tumör- och cellbiologi, Karolinska Institutet, 2009

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI